Table 9.12a

Adjusted Patient Survival, Deceased Donor Liver Transplants

Survival at 3 Months, 1 Year, 3 Years, and 5 Years

  3 Months 1 Year 3 Years 5 Years
(Tx 2003 - 2004) (Tx 2003 - 2004) (Tx 2001 - 2004) (Tx 1999 - 2004)
N % Std. Err. N % Std. Err. N % Std. Err. N % Std. Err.
Total All 9,613 93.2% 0.3% 9,613 87.0% 0.3% 17,892 79.0% 0.4% 25,762 73.3% 0.4%
Primary Diagnosis Non-Cholestatic Cirrhosis 5,937 93.8% 0.3% 5,937 86.9% 0.5% 11,393 78.5% 0.5% 16,727 71.8% 0.5%
Cholestatic Liver Disease/Cirrhosis 856 93.6% 0.8% 856 89.7% 1.0% 1,675 83.7% 1.0% 2,513 81.0% 0.9%
Acute Hepatic Necrosis 747 89.6% 1.1% 747 84.0% 1.4% 1,379 74.5% 1.4% 2,085 70.2% 1.2%
Biliary Atresia 313 92.2% 2.1% 313 90.8% 2.3% 598 85.8% 2.2% 892 85.4% 1.7%
Metabolic Diseases 307 92.5% 1.6% 307 87.6% 2.0% 597 82.7% 1.9% 864 79.6% 1.7%
Malignant Neoplasms 759 93.1% 0.9% 759 85.9% 1.3% 1,188 74.8% 1.6% 1,350 64.1% 2.3%
Other 694 92.6% 1.0% 694 86.4% 1.3% 1,062 81.1% 1.4% 1,331 74.7% 1.6%


Source: OPTN/SRTR Data as of May 1, 2006.

(+) = Values not determined due to insufficient follow-up. (-) = Values not determined since there were no transplants in the category.

Cohorts are transplants performed during the years listed at the top of the table.

Patient survival follows patients from first transplant of this type until death. Counts for patient and graft survival are different because a patient may have more than one transplant for a type of organ.

Center volume = Center's yearly transplants performed during the base period, based on liver transplants.

Multi-organ transplants are excluded.

Survival rates are adjusted to the characteristics of the 3 month and 1 year cohort. See Technical Notes for details.